Follow-up study for testicular cancer after recent treatment
Part of Cancer, Hormones & metabolism, Kidney & urinary clinical trials.
This study looks at how people with testicular cancer are doing after finishing treatment. It mainly focuses on follow-up visits (surveillance) and whether you are in remission, which can help doctors understand and improve post-treatment care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign a consent form and agree to take part
- Your testicular cancer has been confirmed under a microscope as either seminoma or non-seminoma
- Your cancer is recently treated and you are in remission based on scan or bloodwork results (as allowed in the study)
- You finished treatment within the last 6 months
- You can attend regular follow-up appointments and follow the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how testicular cancer and its treatments affect your quality of life and daily function. Researchers want to learn more about the long-term outcomes of surgery so they can better support patients like you.
This study looks at how people should be followed after treatment for testicular cancer (surgery and, for some, chemotherapy). It may help improve follow-up plans while keeping an eye out for cancer coming back.
This Phase 2 study compares two ways of checking your cancer follow-up: a doctor or nurse visits in person versus remote monitoring by phone and imaging. The goal is to see whether remote monitoring can safely replace or match in-person care for certain low-risk cancers and after surgery.
This study compares giving radiation versus observation (no immediate radiation) for men with advanced seminoma whose PET-CT scan shows a leftover mass after first-line chemotherapy. It aims to see which approach controls the disease better while protecting quality of life.
This Phase 2 study tests a treatment plan guided by a PET scan over time in people with seminoma after testicle removal. It aims to tailor therapy based on how cancer shows up on the scan, potentially helping avoid unnecessary treatment intensity.
This trial tests lowering the intensity of treatment (de-escalation) for Stage II seminoma, a type of testicular cancer. You may receive either a surgery to remove lymph nodes or a single round of chemotherapy (carboplatin), instead of more aggressive standard treatments, to see if it's safe and effective.
Hear when a new Testicular Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.